IHS Chemical Week

EnviroTech :: Biotech

Symrise Enters Health Sector

10:16 AM MDT | April 28, 2008 | Kate Phillips

Symrise says it has entered the health market through a strategic partnership with Cambridge Theranostics (Cambridge, U.K.), a bio-tech firm specializing in the diagnostics and prophylaxis of cardiovascular diseases. Symrise says it will contribute up to €8 million ($12.7 million) in “milestone-related payments” toward the development and clinical evaluation of new health and medical food products, under terms of the deal. Both companies will share profits on products resulting from the collaboration, Symrise says. Cambridge Theranostics will use...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa